Accès ouvert
2025
review
OpenAlex
Maria Lorenzi, Stephen Ebohon, Jennifer Kissner, Jedd Comiskey et autres
This study aimed to determine the relative efficacy of bevacizumab gamma (an ophthalmic formulation of bevacizumab) versus alternative interventions relevant to the treatment of neovascular age-related macular degeneration (nAMD) in the United Kingdom (UK) via a systematic literature review (SLR) and network …
us, gb
(code pays fourni par la source)
Accès ouvert
2025
review
OpenAlex
Maria Lorenzi, Sarah Ali, Sarah Cadarette, Stephen Ebohon et autres
INTRODUCTION: At least 50% of patients with immunoglobulin A nephropathy (IgAN) reach kidney failure within 12 years of diagnosis. Delayed progression to kidney failure remains the gold standard treatment endpoint in IgAN, but the prolonged time course limits feasibility as a primary …
us, gb, kr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Norbert Albers, Sarah Cadarette, Benjamin G. Feakins, María Arregui et autres
Long-acting growth hormone (LAGH) has the potential to improve adherence and outcomes over daily somatropin in growth hormone deficiency (GHD). Whereas daily somatropin products are molecularly identical, LAGHs are molecularly distinct; additional moieties or mechanisms that prolong LAGH action confer unique pharmacodynamic/pharmacokinetic …
de, us, gb, dk
(code pays fourni par la source)
Accès ouvert
2021
review
OpenAlex
Kevin Woo, Caroline Dowsett, Ben Costa, Stephen Ebohon et autres
Abstract The aim of this study was to summarise the clinical evidence supporting almost 40 years of topical cadexomer iodine (CIOD) use in wound bed preparation by removing barriers to healing such as exudate, slough, bioburden, and infection and allowing chronic wound …
ca, gb, au, us
(code pays fourni par la source)
2020
review
OpenAlex
Christoph Kolja Boese, Stephen Ebohon, Christian Ries, Diarmuid De Faoite
de, gb, ch
(code pays fourni par la source)